Display options
Cite
Navarra G, Pagano C, Pacelli R, et al. N. Front Oncol. 2020;9:1498doi: 10.3389/fonc.2019.01498.
Navarra, G., Pagano, C., Pacelli, R., Crescenzi, E., Longobardi, E., Gazzerro, P., Fiore, D., Pastorino, O., Pentimalli, F., Laezza, C., & Bifulco, M. (2019). N. Frontiers in oncology, 91498. https://doi.org/10.3389/fonc.2019.01498
Navarra, Giovanna, et al. "N." Frontiers in oncology vol. 9 (2019): 1498. doi: https://doi.org/10.3389/fonc.2019.01498
Navarra G, Pagano C, Pacelli R, Crescenzi E, Longobardi E, Gazzerro P, Fiore D, Pastorino O, Pentimalli F, Laezza C, Bifulco M. N. Front Oncol. 2020 Jan 14;9:1498. doi: 10.3389/fonc.2019.01498. eCollection 2019. PMID: 31993371; PMCID: PMC6971108.
Copy Download .nbib Format: NLM
Share it on

Front Oncol. 2020 Jan 14;9:1498. doi: 10.3389/fonc.2019.01498. eCollection 2019.

N.

Frontiers in oncology

Giovanna Navarra, Cristina Pagano, Roberto Pacelli, Elvira Crescenzi, Elena Longobardi, Patrizia Gazzerro, Donatella Fiore, Olga Pastorino, Francesca Pentimalli, Chiara Laezza, Maurizio Bifulco

Affiliations

  1. Department of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II," Naples, Italy.
  2. Department of Advanced Biomedical Sciences, Federico II University School of Medicine, Naples, Italy.
  3. Institute of Endocrinology and Experimental Oncology, Institute of Endocrinology and Experimental Oncology (IEOS), National Research Council (CNR), Naples, Italy.
  4. Section of Pharmacology, Department of Neuroscience University of Naples Federico II, Naples, Italy.
  5. Department of Pharmacy, University of Salerno, Naples, Italy.
  6. Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy.

PMID: 31993371 PMCID: PMC6971108 DOI: 10.3389/fonc.2019.01498

Abstract

Glioblastoma is among the most common malignant brain tumors and has a dismal prognosis due to the poor response to therapeutic regimens such as ionizing radiation and DNA-alkylating agents. In our study, we investigated the radiosensitizing activity of the N

Copyright © 2020 Navarra, Pagano, Pacelli, Crescenzi, Longobardi, Gazzerro, Fiore, Pastorino, Pentimalli, Laezza and Bifulco.

Keywords: RAD51; STAT5a/b; apoptosis; glioblastoma cells; iPA

References

  1. Mol Biol Cell. 2003 Jan;14(1):40-53 - PubMed
  2. Int J Cancer. 2017 Feb 15;140(4):959-972 - PubMed
  3. Sci Rep. 2017 Oct 26;7(1):14123 - PubMed
  4. Cancer Res. 2005 Dec 15;65(24):11384-91 - PubMed
  5. J Med Chem. 2014 Sep 25;57(18):7798-803 - PubMed
  6. Cancer Treat Rev. 2015 Jan;41(1):35-45 - PubMed
  7. Nat Rev Cancer. 2008 Mar;8(3):193-204 - PubMed
  8. Cancer Res. 2002 Jan 1;62(1):219-25 - PubMed
  9. Clin Cancer Res. 2008 Feb 1;14(3):931-8 - PubMed
  10. Oxid Med Cell Longev. 2016;2016:6012642 - PubMed
  11. Mol Cell. 2017 Jun 15;66(6):801-817 - PubMed
  12. Neuro Oncol. 2014 Oct;16(10):1313-23 - PubMed
  13. Int J Cancer. 2018 Jan 1;142(1):176-190 - PubMed
  14. Trends Cancer. 2015 Dec;1(4):252-265 - PubMed
  15. Genes Cancer. 2013 Sep;4(9-10):401-8 - PubMed
  16. Gene Ther. 2007 Aug;14(15):1143-51 - PubMed
  17. FASEB J. 2014 Mar;28(3):1132-44 - PubMed
  18. Cancer Res. 2006 Sep 1;66(17):8352-5 - PubMed
  19. Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1251-5 - PubMed
  20. Pract Radiat Oncol. 2016 Jul-Aug;6(4):217-25 - PubMed
  21. Adv Cancer Res. 2010;108:73-112 - PubMed
  22. Nature. 2001 May 3;411(6833):102-7 - PubMed
  23. Br J Radiol. 2012 Sep;85(1017):e770-81 - PubMed
  24. J Leukoc Biol. 2013 Dec;94(6):1207-19 - PubMed
  25. J Biol Chem. 2001 Jul 6;276(27):24638-44 - PubMed
  26. Cancer Lett. 2015 Jan 28;356(2 Pt B):454-61 - PubMed
  27. Cold Spring Harb Perspect Biol. 2013 Sep 01;5(9):null - PubMed
  28. Environ Mol Mutagen. 2015 Jul;56(6):491-504 - PubMed
  29. J Neurooncol. 2017 Sep;134(3):513-521 - PubMed
  30. Clin Cancer Res. 2018 Apr 15;24(8):1917-1931 - PubMed
  31. Methods. 2001 Dec;25(4):402-8 - PubMed
  32. Cancer Res. 2003 Nov 1;63(21):7377-83 - PubMed
  33. Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):928-42 - PubMed
  34. FASEB J. 2006 Mar;20(3):412-8 - PubMed
  35. J Med Chem. 2012 Apr 12;55(7):3011-20 - PubMed
  36. Br J Cancer. 2014 Sep 9;111(6):1139-49 - PubMed
  37. Oncotarget. 2016 Oct 25;7(43):70869-70880 - PubMed
  38. Anticancer Agents Med Chem. 2008 Feb;8(2):200-4 - PubMed
  39. N Engl J Med. 2005 Mar 10;352(10):987-96 - PubMed
  40. Mol Cancer. 2013 Aug 02;12:86 - PubMed
  41. Mayo Clin Proc. 2017 Jun;92(6):995-1004 - PubMed
  42. Eur J Gynaecol Oncol. 2005;26(6):589-98 - PubMed
  43. Ann Transl Med. 2016 Feb;4(3):54 - PubMed

Publication Types